Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more abo ...Show more
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ...Show more
Dr. Halley Alexander talks with Dr. Vineet Punia about factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. Read the related article in JAMA. Disclosures can be found at Neu ...Show more
Seizure Recurrence in Generalized Epilepsy After Switching Away From Valproate
Dr. Halley Alexander talks with Dr. Emanuele Cerulli Irelli about the research on seizure recurrence in women with idiopathic generalized epilepsy who switch from valproate to another medication. Read the related article in Neurology. This podcast is sponsored by argenx. Visit ww ...Show more
National Association of Epilepsy Centers Updated Guidelines
Dr. Howard Goodkin talks with Dr. Fred Lado about the National Association of Epilepsy Centers (NAEC) updated guidelines for specialized epilepsy centers. Read the related article in Neurology. Disclosures can be found at Neurology.org.
<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">Retrospective cohort study looked at return rate of discharged patients after receiving either phen ...Show more